Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer

Author(s):
Leila PouraliLeila Pourali1, Ali Taghizadeh kermaniAli Taghizadeh kermani2,*, Mohammad Reza GhavamnasiriMohammad Reza Ghavamnasiri3, Fahimeh KhoshrooFahimeh Khoshroo3, Sare HosseiniSare Hosseini3, Mehdi  AsadiMehdi Asadi4, Kazem AnvariKazem Anvari3
1Women's Health Research Center, Ghaem Hospital, Faculty of Medicine , Mashhad University of Medical Sciences, Mashhad, Iran
2Surgical Oncology Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Cancer Research Center, Omid Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3Cancer Research Center, Omid Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
4Surgical Oncology Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

International Journal of Cancer Management:Vol. 6, issue 3; e80423
Published online:Sep 30, 2013
Article type:Research Article
Received:Jun 18, 2013
Accepted:Jul 17, 2013
How to Cite:Pourali L, Taghizadeh kermani A, Ghavamnasiri MR, Khoshroo F, Hosseini S, et al. Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer. Int J Cancer Manag. 2013;6(3):e80423. doi:

Abstract

Fulltext

The Full text is available in PDF.

Similar Articles

27
Sep
2016

Frequency of Chemotherapy Induced Anemia in Breast Cancer Patients

Leila Pourali,
Ali Taghizadeh,
Mohammad Reza Akhoundi,
Fatemeh Varshoei,
Ahmadreza Zarifian,
Mohammad Sobhan Sheikh Andalibi

Pourali L, Taghizadeh A, Akhoundi MR, Varshoei F, Zarifian A, et al. Frequency of Chemotherapy Induced Anemia in Breast Cancer Patients. Int J Cancer Manag. 2017;10(1):e4672. doi: https://doi.org/10.17795/ijcp-4672

21
Aug
2019

Comparing adverse effects of docetaxel-doxorubicin and paclitaxel-doxorubicin regimens in breast cancer patients

Sakineh Baghbeheshti,
Shadi Baniasadi

Baghbeheshti S, Baniasadi S. Comparing adverse effects of docetaxel-doxorubicin and paclitaxel-doxorubicin regimens in breast cancer patients. koomesh. 2019;21(3):e153948. doi:

25
Jan
2021
 Jundishapur J Chronic Dis Care

Evaluating the Risk Factors and Induced Cardiotoxicity in Breast Cancer Patients

Samira Razaghi,
Sasan Razmjoo,
Mitra Ranjbaran,
Habib Haybar

Razaghi S, Razmjoo S, Ranjbaran M, Haybar H. Evaluating the Risk Factors and Induced Cardiotoxicity in Breast Cancer Patients. Jundishapur J Chronic Dis Care. 2021;10(1):e105994. doi: https://doi.org/10.5812/jjcdc.105994

30
Apr
2015

Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the Literature

Mehrdad Payandeh,
Reza Khodarahmi,
Masoud Sadeghi,
Edris Sadeghi

Payandeh M, Khodarahmi R, Sadeghi M, Sadeghi E. Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the Literature. Int J Cancer Manag. 2015;8(2):e80601. doi:

16
Aug
2025

The Effect of Intravenous Iron Therapy in Chemotherapy-Induced Anemia in Patients with Non-metastatic Breast Cancer

Nasrin Namdari,
Mahya Amini,
Zahra Ghazanfari,
Shirin Haghighat

Namdari N, Amini M, Ghazanfari Z, Haghighat S. The Effect of Intravenous Iron Therapy in Chemotherapy-Induced Anemia in Patients with Non-metastatic Breast Cancer. Shiraz E-Med J. 2026;26(10):e160759. doi: https://doi.org/10.5812/semj-160759

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles